Results 201 to 210 of about 16,081 (221)

Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients

Clinical Microbiology and Infection, 2011
Alexandre Alanio, Guillaume Desoubeaux, C Sarfati   +2 more
exaly  

Clinical characteristics and risk factors forPneumocystis jiroveciipneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients

Modern Rheumatology, 2013
Ryuji Koike, Fumikazu Sakai, Haruhito Sugiyama   +2 more
exaly  

Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries

Scandinavian Journal of Infectious Diseases, 2013
Josep M Llibre, Boris Revollo, Arelly Ornelas   +2 more
exaly  

Pneumocystis jirovecii pneumonia

openaire   +2 more sources

β-d-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia

Clinical Microbiology and Infection, 2011
Dirk Wagner
exaly  

Pneumocystis Jirovecii Pneumonia

2005
openaire   +1 more source

Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis

Transplant Infectious Disease, 2011
Mark G J De Boer, Saskia Le Cessie, Johan W De Fijter   +2 more
exaly  

Pneumocystis jirovecii pneumonia at chest High-resolution Computed Tomography (HRCT) in non-HIV immunocompromised patients: Spectrum of findings and mimickers

European Journal of Radiology, 2019
Lorenzo Cereser, Anna Candoni, Elda Righi   +2 more
exaly  

Pneumocystis jirovecii Pneumonia Versus Histoplasmosis

2022
James A. Mays, Joshua A. Lieberman, Haodong Xu   +2 more
openaire   +1 more source

Pneumocystis jirovecii Pneumonia in the Non–HIV-Infected Population

Annals of Pharmacotherapy, 2016
exaly